TP
Tempest Therapeutics, Inc.
TPST · NASDAQ
$0.97 +2.72% (+$0.03)
1M -6.92%
Market Cap $14.2M
P/E Ratio -
Div. Yield -
ROE 1,270.11%
Bulios Fair Price
$1.38
42.6% upside
Trenutna cena
$0.97
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TPST trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
EV/FFO N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 28.33%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 628.18%
Asset turnover 0.00x
ROE 1,270.11%
Debt
0 /100
High Current ratio 0.38x
Int. coverage -1,759.91x
Debt/Equity N/A
Stability
19 /100
Unstable Beta -1.66x
Profitable years 0
EPS volatility 203.84%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TPST
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Matthew Angel
Employees
4
Headquarters
Brisbane
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report